Page 61 - brain-eBook
P. 61

Team Project Name                                  6.Patent Application: We are in the process of drafting a U.S.
                                                                 patent application to protect our technological innovations,
            Combining closed-loop transcutaneous auricular vagus nerve   which will help to ensure the uniqueness and commercial
            stimulation and focal transcranial direct current stimulation as   value of our research findings.
            an adjuvant treatment for acute and subacute strokes  Key Words
            Research Project                                   Acute Stroke, Subacute Stroke, Transcutaneous Auricular

            This neuroscience project is centered on combining two   Vagus Nerve Stimulation, Focal Transcranial Direct Current
            innovative electrical stimulation techniques: closed-loop   Stimulation, Autonomic Nervous System Modulation,
            transcutaneous auricular vagus nerve stimulation (ctaVNS)   Rehabilitation, Feedback Control, National Cheng Kung
            and focal transcranial direct current stimulation (ftDCS),   University, National Cheng Kung University Hospital
            to treat acute and subacute strokes innovatively. ctaVNS   Global Cooperation
            activates the parasympathetic nervous system, balancing
            the heightened sympathetic state during the acute phase   1. Technology Development and Optimization: Collaborate
            and enhancing neural plasticity in the subacute phase.   with international experts and institutions in the fields of
            Meanwhile, ftDCS uses spatial filtering technology to limit   neural modulation technology, biomedical engineering,
            the area of electrical stimulation, reducing brain injury in the   or medical device design to jointly develop and optimize
            acute phase and strengthening local neural plasticity.  the Transcutaneous Auricular Vagus Nerve Stimulation
                                                                 (ctaVNS) and Focal Transcranial Direct Current
                                                                 Stimulation (ftDCS) technologies.
            In the first year of the project, our focus has been on the   2. Clinical Trial Expansion: Partner with international medical
            development and clinical validation of the closed-loop   institutions to conduct broader multi-center clinical trials,
            auricular vagus nerve stimulator. Our achievements to date   enhancing the validity and universality of the data.
            include:                                           3. Data Analysis and Sharing: Work with international data
            1.Technology  Development  and  Innovation:  We  have   science teams for in-depth analysis of collected clinical
              successfully developed the ear vagus nerve circuit   data. Share data and research findings to promote
              and related software, which are key components for   knowledge sharing and technological progress globally.
              realizing the ctaVNS technology. Our system is capable   4. Standard Setting and Regulation Development: Participate
              of dynamically adjusting stimulation intensity based on   in international standardization organizations to jointly
              the patient's physiological responses, representing a   establish standards for medical devices and treatment
              significant innovation in the field of neural modulation.  methodologies.
            2.Prototype Design: Our team is currently working on the   5. Academic Exchange and Joint Publication: Cooperate with
              design of the prototype, ensuring that the device is not   international academic institutions for exchanges and joint
              only functionally advanced but also meets high standards   publication of research results, increasing the international
              in user experience.                                impact of the research.
            3.Animal Experiment Validation: We have conducted   7.  Technology Transfer and Commercialization: Find
                                                                 international partners to explore possibilities for
              experiments on animal models to verify that our treatment   technology transfer and commercialization, expanding the
              method can significantly improve autonomic nervous   market reach of the technology.
              function, blood pressure control, motor recovery, and   8.  Professional Training and Education: Collaborate with
              behavioral performance post-stroke.                international educational institutions to initiate professional
            4.Human Clinical Trials: We are currently conducting human   training and educational programs, nurturing future
              clinical trials to further prove the effectiveness and safety   experts in neuroscience.
              of our method, which is a crucial step towards clinical
              application.                                     Project Web Page
            5.Preparation for Commercialization:  The team has
              completed a competitive product analysis and is actively
              engaged in regulatory pathway research and patent
              investigation, preparing to transform our research results
              into marketable products.


 60                                                                                                          61
   56   57   58   59   60   61   62   63   64